Next Article in Journal
Differences in Anthocyanin Accumulation Profiles between Teinturier and Non-Teinturier Cultivars during Ripening
Previous Article in Journal
Trends in Sales and Industry Perspectives of Package Sizes of Carbonates and Confectionery Products
Previous Article in Special Issue
Validation of Antiobesity Effects of Black Soybean Seed Coat Powder Suitable as a Food Material: Comparisons with Conventional Yellow Soybean Seed Coat Powder
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 10
Issue 5
10.3390/foods10051072
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Protective Effect of Gochujang on Inflammation in a DSS-Induced Colitis Rat Model

by
Patience Mahoro
1,†,
Hye-Jung Moon
1,†,
Hee-Jong Yang
2,
Kyung-Ah Kim
3 and
Youn-Soo Cha
1,4,*
1
Department of Food Science and Human Nutrition & Obesity Research Center, Jeonbuk National University, Jeonju 54896, Korea
2
Microbial Institute for Fermentation Industry (MIFI), Sunchang 56048, Korea
3
Department of Food and Nutrition, Chungnam National University, Daejeon 34134, Korea
4
Obesity Research Center, Jeonbuk National University, Jeonju 54896, Korea
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to the work.
Foods 2021, 10(5), 1072; https://doi.org/10.3390/foods10051072
Submission received: 25 March 2021 / Revised: 28 April 2021 / Accepted: 10 May 2021 / Published: 12 May 2021
(This article belongs to the Special Issue Soybean Processing and Utilization)
Browse Figures
Versions Notes

Abstract

:
Gochujang is a traditional Korean fermented soy-based spicy paste made of meju (fermented soybean), red pepper powder, glutinous rice, and salt. This study investigated the anti-inflammatory effects of Gochujang containing salt in DSS-induced colitis. Sprague–Dawley (SD) rats were partitioned into five groups: normal control, DSS control, DSS + salt, DSS + mesalamine, and DSS + Gochujang groups. They were tested for 14 days. Gochujang improved the disease activity index (DAI), colon weight/length ratio, and colon histomorphology, with outcomes similar to results of mesalamine administration. Moreover, Gochujang decreased the serum levels of IL-1β and IL-6 and inhibited TNF-α, IL-6, and IL-1β mRNA expression in the colon. Gochujang downregulated the expression of iNOS and COX-2 and decreased the activation of NF-κB in the colon. Gochujang induced significant modulation in gut microbiota by significantly increasing the number of Akkermansia muciniphila while decreasing the numbers of Enterococcus faecalis and Staphylococcus sciuri. However, compared with the DSS group, the salt group did not significantly change the symptoms of colitis or cytokine levels in serum and colon. Moreover, the salt group significantly decreased the gut microflora diversity. Gochujang mitigated DSS-induced colitis in rats by modulating inflammatory factors and the composition of gut microflora, unlike the intake of salt alone.

Graphical Abstract

1. Introduction

Inflammatory bowel disease (IBD) comprises bowel abnormalities that cause chronic inflammation of the gastrointestinal (GI) tract. Crohn’s disease (CD) and ulcerative colitis (UC) are the two major forms of IBD and are marked by periods of quiescence or activity [1]. Both forms are life-threatening and are among the three top factors that contribute to colorectal cancer. However, UC is more frequently reported as a causal agent of colorectal cancer than is CD [2]. Management of this relapsing-remitting disorder includes corticosteroids, immunomodulators, and amino salicylates, such as mesalamine, a targeting remission of inflammation along with maintenance of the quiescent state of the disease [3,4]. Healthy dietary habits play a key role in alleviating UC symptoms [5,6]. Further, several studies have shown that fermented foods have a positive effect on intestinal health by influencing the profile and function of gut microbiota [7,8,9].
In contrast, constant exposure to a high level of salt (NaCl) in the diet modulates gut microbiota composition and function by promoting a predisposition to disease through a pro-inflammatory state in the gut. Research revealed that feeding mice a salt-enriched diet worsens experimentally-induced colitis [10]. A high salt diet (HSD) helps to sustain the pro-inflammatory microbiota by weakening fecal microflora activity and structure in the colonic community, as well as by suppressing mucosal immunity of the upper part of intestine, which in turn induces expression of pro-inflammatory genes and promotes inflammatory disorders [11].
Gochujang, a traditional Korean fermented condiment, consists of glutinous rice, meju (fermented soybean) powder, red pepper powder, and a large amount of salt [12]. Gochujang as a fermented food has been suggested to help reduce the risk of several health conditions (due to its anti-cancer properties [13]), insulin resistance [14], anti-obesity properties [15], and antioxidant capacity [16]. Gochujang contains 5~11% salt, but its main bioactive compounds have been identified as capsaicin of red pepper powder, isoflavones of meju, and probiotics [12,17,18]. According to reports, these components help in alleviating colitis symptoms through their anti-inflammatory activities [19,20,21,22,23,24,25]. However, there is a lack of research on reducing signs and symptoms of colitis with Gochujang.
Therefore, we hypothesized that Gochujang could exert an anti-inflammatory effect. This experiment evaluated the potential protective functions of Gochujang containing high salt against dextran sodium sulfate (DSS)-induced colitis in Sprague–Dawley rats (SD rats).

2. Materials and Methods

2.1. Animal Study

All animal-related processes were performed in accordance with an experimental plan endorsed by the Animal Ethics Committee of Jeonbuk National University (CBNU 2020-073). SD rats (5 weeks old, male, 200–220 g body weight) were ordered from DooYeol Biotech (Seoul, Korea) to be housed under a light-controlled cycle (12 h), at 23 ± 2 °C and with humidity regulated at 55 ± 5%. They were allowed unrestricted access to food (AIN-93 laboratory diet) and drinking water. Gochujang was provided by the Microbial Institute for Fermentation Industry (Sunchang-gun, Jeollabuk-do, Korea).
Following a one-week acclimatization period, rats were used in a 14-day experiment, beginning with a random split into five groups (n = 7): normal control (NOR), DSS control (DSS), DSS + salt (SAL), DSS + mesalamine (MES), and DSS + Gochujang (GCJ). Colitis was induced during 7 days in DSS, SAL, MES, and GCJ groups through free access to drinking water with a DSS concentration of 3% (DSS molecular weight: 36–50 kDa, MP Biomedicals, Irvine, CA, USA); followed by a 7-day recovery phase of drinking water without DSS until sacrifice. All experimental solutions were administered orally throughout the duration of the whole 14-day experiment (Figure S1). The normal and DSS groups received vehicle (distilled water), the SAL group received salt at 348.6 mg/kg body weight (BW), the MES group received mesalamine at 3.7 mg/kg BW, and the GCJ group received Gochujang at 2 g/kg BW. Gochujang’s salt concentration was determined as 8.72% using Mohr’s method [26], in which the same amount of salt was dissolved in distilled water at 4% NaCl (w/v) and administered based on references regarding the dose of salt in the induction of colitis [10,11,27]. In previous studies, the administration of mesalamine (7.4 mg/kg BW) to mice was shown to prevent colitis [28]. Mesalamine was then administered according to the corresponding surface area dose conversion formula [29].

2.2. Disease Activity Index (DAI) and Sample Collection

In order to assess the severity of acute colitis symptoms, the disease activity index (DAI) was evaluated daily for body weight loss, stool consistency, and bloody stool. On the last day, rats were euthanized and colons were excised from the caeco-colonic junction to the rectum. Excised colons were measured for length and weight after the stool was removed. Part of the colon was fixed in 10% buffered formalin solution for histological analysis. The remaining colon tissue was opened longitudinally, frozen in liquid nitrogen, and stored at −70 °C.

2.3. Histological Analysis

Staining of colon tissues fixed in 10% formalin was performed in the Korean Pathology Technical Center (KP&T, Cheongju, Korea). In brief, after being embedded in paraffin, the tissues were excised into 5-mm-thick sections and then dyed using hematoxylin and eosin (H&E). The samples were analyzed at ×100 magnification by Axiophot Zeiss ZI microscope (Carl Zeiss, Gottingen, Germany) installed in the Center for University-wide Research Facilities (CURF) at Jeonbuk National University.

2.4. Enzyme-Linked Immunosorbent Assay (ELISA)

The serum concentrations of inflammatory-associated cytokines such as tumor necrosis factor-alpha (TNF-α), IL-6, and IL-1β were assessed via commercial ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions.

2.5. Quantitative Real-Time PCR (qRT-PCR) Analysis

The expression of the roles of inflammation-related genes TNF-α, IL-1β, and IL-6 in the colonic tissue was determined by a qRT-PCR assay. Total RNA was extracted via the QIAGEN RNA easy mini kit (QIAGEN GmbH, Hilden, Germany), followed by the determination of purity. Further, cDNA was generated using a cDNA reverse transcription kit (TaKaRa Bio, Otsu, Japan), and real-time PCR was executed using a SYBR Green PCR Master Mix (Toyobo, Osaka, Japan). The primer sets used in this study are listed in Table 1.

2.6. Western Blot Analysis

Immunoblot analysis was performed to determine the relative expression of phosphoprotein p65 (p-p65), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) in the colon mucosa. Protein extract was derived from colon tissue emulsified in RIPA lysis buffer (Pierce-Thermo Fisher Scientific, Rockford, MD, USA) mixed with a 1% protease inhibitor and 1% phosphatase inhibitor cocktail (Roche Diagnostics GmbH, Mannheim, Germany). After separating the protein using SDS-polyacrylamide gel electrophoresis, it was transferred onto polyvinylidene difluoride membranes (Bio-Rad Laboratories, Hercules, CA, USA). After the membrane was blocked in 5% skim milk, it was washed with phosphate buffered saline with 0.1% tween 20 (PBS-T). Primary antibodies for p-p65, p65, iNOS, COX-2, and β-actin were purchased from Cell Signaling Technology (Beverly, MA, USA). These were applied overnight at 4 °C and washed with PBS-T. After reacting for 45 min at room temperature with a secondary antibody (Santa Cruz Biotechnologies Inc., Santa Cruz, CA, USA), they were washed with PBS-T, followed by measurement of p-p65, p65, iNOS, COX-2, and β actin expression supported by a ChemiDoc MP imaging system (Bio-Rad, Hercules, CA, USA).

2.7. Gut Microbiota Analysis

Fecal samples were frozen in liquid nitrogen and stored at −80 °C until further analyzed. Bacterial genomic DNA from feces was extracted via the Fast DNA Spin kit for soil (MP Bio Laboratories, USA). For amplicon sequencing, PCR reactions were performed targeting the V1, V2, and V3 polymorphic regions of the 16S rRNA genes using the appropriate primer with a barcode. The PCR product was confirmed by 2% agarose gel electrophoresis, and impurities other than the amplification product were removed using a QIAquik PCR purification kit (Qiagen, Valencia, CA, USA). The same amount of PCR product was collected and purified again using the AMPure bead kit (Agencourt Bioscience, Beverly, MA, USA). Then, the length and concentration of the amplified products were confirmed with Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) using a DNA 7500 chip. The final amplification was performed by Macrogen Co., Ltd. (Seoul, Korea) according to the manufacturer’s manual using the GS Junior Titanium system (Roche, Germany) sequencer.

2.8. Statistics and Analysis

To analyze statistical differences, data were compared using one-way ANOVA in SPSS (version 17.0; SPSS, Inc., Chicago, IL, USA). The significant differences among the groups were analyzed by the Duncan’s multiple range test (p < 0.05). Data are expressed as the mean ± standard deviation (SD).

3. Results

3.1. Effect of Gochujang on UC Symptoms

UC symptoms were evaluated based on factors such as body weight, DAI, and colon-related features. For final body weight, the DSS and SAL groups showed significantly lower body weights than the NOR group, while weights in both the GCJ and MES groups were significantly higher than that of the DSS group (Figure 1A). As shown in Figure 1B, the DSS group was significantly lower in weight gain compared with the other groups (p < 0.05). The DAI score was highest on the 8th day in the DSS group and on the 10th day in the SAL group. On the 14th day, the last day of the experiment, the MES and GCJ groups showed significantly lower DAI scores compared with the DSS and SAL groups (p < 0.05) (Figure 1C,D).

3.2. Effect of Gochujang on Colon Damage

We evaluated the reduction in colon length and colon weight/length ratio, as well as other indicators of colorectal inflammation (Figure 2A,B). Colon length was significantly shorter in the DSS and SAL groups compared with the NOR group (p < 0.05). However, colons from MES and GCJ groups were significantly longer than those of the DSS and SAL groups (p < 0.05). In addition, the colon weight/length ratio was significantly lower in MES and GCJ groups than in DSS and SAL groups (p < 0.05). Therefore, Gochujang produced alleviation of the symptoms of DSS-induced colitis.
The pathological changes in colon tissue were confirmed by H&E staining (Figure 2C). The DSS and SAL groups indicated crypt disruption of epithelial cells, infiltration of inflammatory cells into mucosa, and loss of goblet cells in the colon. Orally administered mesalamine and Gochujang pre-treatments lowered the histopathological alterations induced by DSS, including decreasing inflammatory cell infiltration, goblet cell depletion, and crypt destruction. This resulted in lesser epithelial changes compared with the DSS and SAL groups. Altogether, these results demonstrated that Gochujang had a preventive effect against colon tissue damage.

3.3. Effect of Gochujang on Serum Levels of Pro-Inflammatory Cytokine

To investigate the anti-inflammatory effect of Gochujang, serum levels of TNF-α, IL-6, and IL-1β were measured (Table 2). The levels of IL-6 and IL-1β in serum were significantly increased in the DSS and SAL groups compared with the NOR group (p < 0.05). However, MES and GCJ groups showed significantly decreased IL-6 and IL-1β levels compared with DSS and SAL groups. Therefore, Gochujang showed inhibition of pro-inflammatory cytokines in serum of colitis rats.

3.4. Effects of Gochujang on Colonic Inflammation-Related Gene and Protein Expression

The mRNA expression of pro-inflammatory genes TNF-α, IL-6, and IL-1β in colon tissue was analyzed using q-PCR (Figure 3A–C). DSS and SAL treatments significantly upregulated mRNA expression of these inflammation-related genes over that of the NOR group (p < 0.05). Compared with the DSS and SAL groups, the Gochujang and MES groups had lower colonic mRNA expression of TNF-α, IL-6, and IL-1β. Interestingly, the SAL group exhibited the highest mRNA expression of IL-1β, whereas Gochujang administration downregulated IL-1β level more effectively (p < 0.05) than the MES group.
The iNOS and COX-2 contributed to the severity of intestinal damage by triggering excessive production of inflammatory mediators such as transcription factor NF-κB. We studied their protein expression using immunoblotting analyses (Figure 3D). The expression of p-p65 in colon tissue increased in the DSS group compared with the NOR group, whereas the Gochujang group showed decreased level of p-p65 compared with the DSS group (p < 0.05). In addition, the expression of iNOS and COX-2 was downregulated in GCJ and MES groups compared with the DSS group (p < 0.05).

3.5. Effect of Gochujang on Gut Microbiota Dysbiosis

As gut microbiota dysbiosis is associated with colitis, we analyzed the microorganisms in stools to investigate whether Gochujang alters gut microbial composition. To evaluate the abundance and diversity of gut microbiota, the alpha-diversity indices OUT, ACE, Chao, Shannon, Simpson, and phylogenetic diversity were analyzed (Table 3). Although there was no significant difference between the DSS-treated group and the NOR group, the SAL group showed a significant decrease in diversity in all indices compared with the DSS group (p < 0.05). At the phylum level, the major bacteria analyzed in feces were Firmicutes, Proteobacteria, Actinobacteria, and Bacteroidetes (Figure 4A). The DSS group showed no significant difference compared with the NOR group, but the abundance of Bacteroidetes tended to increase in the DSS group. At the order level, there was no significant difference in all groups compared with the NOR group. However, Lactobacillales tended to be increased in all groups treated with DSS, especially the SAL group (Figure 4B). At the species level, the DSS group had significantly higher Enterococcus faecalis and Staphylococcus sciuri, but there was no significant difference in Akkermansia muciniphila compared with the NOR group. Compared with the DSS group, the GCJ group showed significantly decreased E. faecalis and S. sciuri but increased A. muciniphila. There was no significant difference in the composition of E. faecium and L. reuteri in GCJ group compared with DSS group, but there was a tendency to increase. The SAL group showed no significant difference in E. faecalis, A. muciniphila, E. coli, or L. reuteri compared with the DSS group (Table 4).

4. Discussion

Gochujang is a traditional Korean dietary spice paste made from fermentation of meju (fermented soybean powder), glutinous rice, red pepper powder, malts, and salt. The synergy of fermented soy products and red pepper in Gochujang has been reported to have health benefits [30]. Moreover, Gochujang has been ranked in the Korean top-15 most commonly consumed foods and top-2 most appreciated condiment seasonings after kanjang (fermented soy sauce) [31]. High salt intake is discussed as being associated with activation of pro-inflammatory factors in gastric precancerous lesions such as atrophic gastritis, intestinal metaplasia, gastrointestinal cancer, and colitis [27,32]. However, a previous study has reported that kanjang (a Korean fermented soy sauce), though containing a large amount of salt, mitigates DSS-induced colitis. It is suggested that the fermented soy sauce has anti-inflammatory effects compared to salt alone [8]. Therefore, we investigated the anti-inflammatory effect of Gochujang, a fermented soybean product containing high salt, in DSS-induced colitis.
The DSS-induced rodent colitis has been reported as a condition that is morphologically and symptomatically similar to UC conditions seen in human clinical symptoms, such as weight reduction, shortening of colon, bloody stool, and diarrhea, which were assessed by DAI score [33,34]. UC also causes histological changes in colon tissues, such as inflammatory cell infiltrate, epithelial damage, and mucosal disruption [35]. In our study, rats treated with DSS revealed greater weight loss, shorter colon, increased colon tissue damage, and higher DAI score compared with NOR rats. Compared with the DSS treatment group, administration of Gochujang inhibited the clinical symptoms and the epithelial and mucosal damage of colon tissue. Gochujang showed a DAI score similar to that of the positive control group treated with mesalamine. These results suggest that Gochujang effectively inhibits symptoms of colitis. Interestingly, rats treated with salt exhibited a high DAI score similar to those treated with DSS alone. These results were consistent with previous studies in that high-salt diet worsened UC pathogenesis [10,36]. Previous studies described that inflammation of the colon increases the activity of inflammation-related cytokines including TNF-α, IL-1β, and IL-6 in serum and colon tissues in murine colitis [20,24,37]. We analyzed serum levels and colonic gene expression to identify changes in TNF-α, IL-6, and IL-1β. The serum levels of IL-6 and IL-1β were significantly lower in the GCJ group than in the DSS and SAL groups.
The gene expression of TNF-α, IL-6, and IL-1β was reduced in the GCJ group compared to the DSS group. In other colitis mouse models, TNF-α, IL-6, and IL-1β in serum and colon were reduced after administering doenjang, fermented soybean paste, and isoflavones such as daidzein and genistein, which are bioactive compounds of soybeans [9,20,21,38,39]. Some of the bioactive compounds of Gochujang made from meju (fermented soybean) are daidzein and genistein [12,16]. These compounds seem to have reduced pro-inflammatory cytokines [40]. However, the salt group had significantly higher IL-1β gene expression in colon tissues than the DSS group. In previous studies on salt and colitis in mice, high salt showed an increased expression of IL-1β and TNF-α in the colon [10,27]. Therefore, in this colitis model, Gochujang was found to lessen pro-inflammatory markers when compared to salt alone. It has been reported that increased pro-inflammatory cytokines in mucosal epithelial cells with colitis activate the NF-κB signaling pathway [41]. NF-κB is known to regulate the expression of the inflammatory genes iNOS and COX-2. It is known that p65 is a subunit of NF-κB and is phosphorylated to activate the NF-κB signaling pathway [42]. In this study, the expression of inflammation-related proteins p-p65, iNOS, and COX-2 was examined to confirm the inhibitory pathway for colitis. These results showed downregulation of the expression of iNOS and COX-2, reducing the activation of NF-κB in the GCJ group compared with the DSS group. Similar to our study, kanjang showed anti-inflammatory effects by downregulating the expression of iNOS and COX-2 in the colon mucosa of colitis models [8]. In addition, in a rat model of trinitrobenzene sulfonic acid (TNBS)-induced colitis (genistein, a soybean isoflavone) was revealed to be an anti-inflammatory compound with an inhibitory effect on COX-2 expression [43]. Therefore, our findings indicate that Gochujang attenuated colon inflammatory responses by inhibiting the NF-κB signaling pathway.
Recently, the link involving gut microbiota and human diseases has received attention in the scientific literature [44]. Drastic changes in gut microbiota of humans with UC were found to be similar to those seen in rat models of colitis induced by DSS [34]. Moreover, gut microbiota dysbiosis is caused by genetic and environmental factors, which is related to colitis [45]. In this study, we identified the effect of Gochujang on the gut bacterial composition. Compared with the DSS group, the alpha-diversity index was significantly reduced in the SAL group. A previous study reported that high-salt diets exacerbate colitis and alter gut microbiota in DSS and dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice [11]. Our results also revealed that high salt intake reduced the diversity of gut microflora. However, Gochujang containing the same amount of salt did not significantly change the diversity of gut microflora. At the phylum level, the DSS group increased in abundance of Bacteroidetes compared with the NOR group. Increased Bacteroidetes has been reported as a risk factor for colitis, and our results were in agreement with previous studies [46,47]. The abundance of E. faecalis was significantly increased in the DSS group compared with the NOR group. In addition, the abundance of S. sciuri was significantly increased in the DSS group. E. faecalis showed relatively high abundance in the intestine of IL-10-deficient mice and IBD patients and was reported to be associated with colitis induction [48,49]. S. sciuri was found in the colon tissues of patients with colitis and was reported as an oral bacterium that promoted intestinal inflammation in colitis [50,51]. Compared with the DSS group, the GCJ group had significantly reduced abundance of E. faecalis and S. sciuri, and increased abundance of A. muciniphila and L. reuteri, which are known to improve intestinal barrier function and inflammatory response [24,52]. Also, the intake of doenjang was found to increase A. muciniphila in the TNBS-induced colitis model, and our data were similar [9]. Therefore, it was found that Gochujang, unlike the equivalent dose of salt alone, improved the abundance of E. faecalis, A. muciniphila, and L. reuteri in the colitis model. Genistein and daidzein, the isoflavones of soybeans, have been reported to increase the relative abundance of A. muciniphila in mice and also to improve the composition and diversity of intestinal flora [53,54]. Therefore, the change in the composition of the gut flora seems to be caused by the isoflavones contained in Gochujang.

5. Conclusions

In this study, the intake of Gochujang in DSS-induced colitis rats showed anti-inflammatory effects through down-regulation of inflammatory cytokines and suppression of NF-κB signaling pathways in colon, similar to the effects of mesalamine. Gochujang also inhibited the growth of E. faecalis and S. sciuri, which were increased in the UC, and promoted the growth of A. muciniphila and L. reuteri, which are beneficial bacteria. However, salt by itself was found to worsen DSS-induced colitis and reduce the diversity of intestinal flora. These results demonstrated that Gochujang, a fermented food containing a large amount of salt, has a preventive effect on UC unlike the intake of salt alone. Furthermore, additional clinical trials are considered necessary on the preventive effects of Gochujang against colitis.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/foods10051072/s1, Figure S1: Scheme of the animal study.

Author Contributions

P.M. and H.-J.M. contributed equally to this work. Y.-S.C., K.-A.K., and H.-J.Y. conceived and designed the study. P.M., K.-A.K., and H.-J.Y. performed the experiments. All authors analyzed the data. H.-J.M. and P.M. wrote the manuscript. H.-J.M., K.-A.K., and Y.-S.C. corrected the article. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by “Traditional food safety monitoring program” under the Ministry of Agriculture, Food and Rural Affairs and partly Korea Agro-Fisheries and Food trade corporation in 2020. This research was supported by “Research Base Construction Fund Support Program” funded by Jeonbuk National University in 2019.

Institutional Review Board Statement

This study was conducted with the approval of the Animal Ethics Committee of Jeonbuk National University (CBNU 2020-073).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request to the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kaser, A.; Zeissig, S.; Blumberg, R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28, 573–621. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Andersen, N.N.; Jess, T. Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J. Gastroenterol. 2013, 19, 7561–7568. [Google Scholar] [CrossRef] [PubMed]
  3. Lichtenstein, G.R.; Abreu, M.T.; Cohen, R.; Tremaine, W.; American Gastroenterological Associatoin. American gastroenterological association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006, 130, 940–987. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Peyrin-Biroulet, L.; Sandborn, W.; Sands, B.E.; Reinisch, W.; Bemelman, W.; Bryant, R.V.; D’Haens, G.; Dotan, I.; Dubinsky, M.; Feagan, B.; et al. Selecting therapeutic targets in inflammatory bowel disease (stride): Determining therapeutic goals for treat-to-target. Am. J. Gastroenterol. 2015, 110, 1324–1338. [Google Scholar] [CrossRef] [PubMed]
  5. Hrncir, T.; Stepankova, R.; Kozakova, H.; Hudcovic, T.; Tlaskalova-Hogenova, H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: Studies in germ-free mice. BMC Immunol. 2008, 9, 65. [Google Scholar] [CrossRef] [Green Version]
  6. Conlon, M.A.; Bird, A.R. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2014, 7, 17–44. [Google Scholar] [CrossRef]
  7. Bell, V.; Ferrao, J.; Pimentel, L.; Pintado, M.; Fernandes, T. One health, fermented foods, and gut microbiota. Foods 2018, 7, 195. [Google Scholar] [CrossRef] [Green Version]
  8. Song, J.L.; Choi, J.H.; Seo, J.H.; Lim, Y.I.; Park, K.Y. Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice. J. Med. Food 2014, 17, 1027–1035. [Google Scholar] [CrossRef] [Green Version]
  9. Kim, K.A.; Jang, S.E.; Jeong, J.J.; Yu, D.H.; Han, M.J.; Kim, D.H. Doenjang, a korean soybean paste, ameliorates TNBS-induced colitis in mice by suppressing gut microbial lipopolysaccharide production and NF-κB activation. J. Funct. Foods 2014, 11, 417–427. [Google Scholar] [CrossRef]
  10. Monteleone, I.; Marafini, I.; Dinallo, V.; Di Fusco, D.; Troncone, E.; Zorzi, F.; Laudisi, F.; Monteleone, G. Sodium chloride-enriched diet enhanced inflammatory cytokine production and exacerbated experimental colitis in mice. J. Crohns. Colitis 2017, 11, 237–245. [Google Scholar] [CrossRef] [Green Version]
  11. Miranda, P.M.; De Palma, G.; Serkis, V.; Lu, J.; Louis-Auguste, M.P.; McCarville, J.L.; Verdu, E.F.; Collins, S.M.; Bercik, P. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome 2018, 6, 57. [Google Scholar] [CrossRef]
  12. Cho, J.Y.; Lee, H.J.; Shin, H.C.; Lee, J.M.; Park, K.H.; Moon, J.H. Behavior of flavonoid glycosides contained in korean red pepper paste (gochujang) during fermentation: Participation of a β-glucosidase inhibitor. Food Sci. Biotechnol. 2013, 22, 1–8. [Google Scholar] [CrossRef]
  13. Park, K.Y.; Kong, K.R.; Jung, K.O.; Rhee, S.H. Inhibitory effects of kochujang extracts on the tumor formation and lung metastasis in mice. Prev. Nutr. Food Sci. 2001, 6, 187–191. [Google Scholar]
  14. Kwon, D.Y.; Hong, S.M.; Ahn, I.S.; Kim, Y.S.; Shin, D.W.; Park, S. Kochujang, a korean fermented red pepper plus soybean paste, improves glucose homeostasis in 90% pancreatectomized diabetic rats. Nutrition 2009, 25, 790–799. [Google Scholar] [CrossRef]
  15. Ahn, I.S.; Do, M.S.; Kim, S.O.; Jung, H.S.; Kim, Y.I.; Kim, H.J.; Park, K.Y. Antiobesity effect of kochujang (korean fermented red pepper paste) extract in 3T3-L1 adipocytes. J. Med. Food 2006, 9, 15–21. [Google Scholar] [CrossRef]
  16. Lee, D.E.; Shin, G.R.; Lee, S.; Jang, E.S.; Shin, H.W.; Moon, B.S.; Lee, C.H. Metabolomics reveal that amino acids are the main contributors to antioxidant activity in wheat and rice gochujangs (korean fermented red pepper paste). Food Res. Int. 2016, 87, 10–17. [Google Scholar] [CrossRef]
  17. Ryu, J.A.; Kim, E.; Kim, M.J.; Lee, S.; Yoon, S.R.; Ryu, J.G.; Kim, H.Y. Physicochemical characteristics and microbial communities in gochujang, a traditional korean fermented hot pepper paste. Front. Microbiol. 2020, 11, 620478. [Google Scholar] [CrossRef]
  18. Jang, Y.K.; Shin, G.R.; Jung, E.S.; Lee, S.; Lee, S.; Singh, D.; Jang, E.S.; Shin, D.J.; Kim, H.J.; Shin, H.W.; et al. Process specific differential metabolomes for industrial gochujang types (pepper paste) manufactured using white rice, brown rice, and wheat. Food Chem. 2017, 234, 416–424. [Google Scholar] [CrossRef]
  19. Chen, Y.; Le, T.H.; Du, Q.; Zhao, Z.; Liu, Y.; Zou, J.; Hua, W.; Liu, C.; Zhu, Y. Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling. Int. Immunopharmacol. 2019, 71, 144–154. [Google Scholar] [CrossRef]
  20. Zhang, R.; Xu, J.; Zhao, J.; Chen, Y. Genistein improves inflammatory response and colonic function through NF-κB signal in DSS-induced colonic injury. Oncotarget 2017, 8, 61385–61392. [Google Scholar] [CrossRef] [Green Version]
  21. Shen, J.; Li, N.; Zhang, X. Daidzein ameliorates dextran sulfate sodium-induced experimental colitis in mice by regulating NF-κB signaling. J. Environ. Pathol. Toxicol. Oncol. 2019, 38, 29–39. [Google Scholar] [CrossRef]
  22. Kang, C.; Wang, B.; Kaliannan, K.; Wang, X.; Lang, H.; Hui, S.; Huang, L.; Zhang, Y.; Zhou, M.; Chen, M.; et al. Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. mBio 2017, 8, e00470-17. [Google Scholar] [CrossRef] [Green Version]
  23. Bessler, H.; Djaldetti, M. Capsaicin modulates the immune cross talk between human mononuclears and cells from two colon carcinoma lines. Nutr. Cancer 2017, 69, 14–20. [Google Scholar] [CrossRef]
  24. Wang, G.; Huang, S.; Cai, S.; Yu, H.; Wang, Y.; Zeng, X.; Qiao, S. Lactobacillus reuteri ameliorates intestinal inflammation and modulates gut microbiota and metabolic disorders in dextran sulfate sodium-induced colitis in mice. Nutrients 2020, 12, 2298. [Google Scholar] [CrossRef]
  25. Chen, Y.; Zhang, L.; Hong, G.; Huang, C.; Qian, W.; Bai, T.; Song, J.; Song, Y.; Hou, X. Probiotic mixtures with aerobic constituent promoted the recovery of multi-barriers in DSS-induced chronic colitis. Life Sci. 2020, 240, 117089. [Google Scholar] [CrossRef]
  26. Korkmaz, D. Precipitation titration: “Determination of chloride by the mohr method”. Methods 2001, 2, 1–6. [Google Scholar]
  27. Tubbs, A.L.; Liu, B.; Rogers, T.D.; Sartor, R.B.; Miao, E.A. Dietary salt exacerbates experimental colitis. J. Immunol. 2017, 199, 1051–1059. [Google Scholar] [CrossRef] [Green Version]
  28. Kong, R.; Luo, H.; Wang, N.; Li, J.; Xu, S.; Chen, K.; Feng, J.; Wu, L.; Li, S.; Liu, T.; et al. Portulaca extract attenuates development of dextran sulfate sodium induced colitis in mice through activation of PPARγ. PPAR Res. 2018, 2018, 6079101. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Nair, A.B.; Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 2016, 7, 27–31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Kwon, D.Y.; Chung, K.R.; Yang, H.J.; Jang, D.J. Gochujang (korean red pepper paste): A korean ethnic sauce, its role and history. J. Ethn. Foods 2015, 2, 29–35. [Google Scholar] [CrossRef] [Green Version]
  31. Kim, S.H.; Kim, M.S.; Lee, M.S.; Park, Y.S.; Lee, H.J.; Kang, S.-A.; Lee, H.S.; Lee, K.-E.; Yang, H.J.; Kim, M.J.; et al. Korean diet: Characteristics and historical background. J. Ethn. Foods 2016, 3, 26–31. [Google Scholar] [CrossRef] [Green Version]
  32. Song, J.H.; Kim, Y.S.; Heo, N.J.; Lim, J.H.; Yang, S.Y.; Chung, G.E.; Kim, J.S. High salt intake is associated with atrophic gastritis with intestinal metaplasia. Cancer Epidemiol. Biomark. Prev. 2017, 26, 1133–1138. [Google Scholar] [CrossRef] [Green Version]
  33. Bojic, D.; Radojicic, Z.; Nedeljkovic-Protic, M.; Al-Ali, M.; Jewell, D.P.; Travis, S.P. Long-term outcome after admission for acute severe ulcerative colitis in oxford: The 1992–1993 cohort. Inflamm. Bowel Dis. 2009, 15, 823–828. [Google Scholar] [CrossRef]
  34. Wang, K.; Jin, X.; You, M.; Tian, W.; Leu, R.K.L.; Topping, D.L.; Conlon, M.A.; Wu, L.; Hu, F. Dietary propolis ameliorates dextran sulfate sodium-induced colitis and modulates the gut microbiota in rats fed a western diet. Nutrients 2017, 9, 875. [Google Scholar] [CrossRef]
  35. Vetuschi, A.; Latella, G.; Sferra, R.; Caprilli, R.; Gaudio, E. Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig. Dis Sci. 2002, 47, 1447–1457. [Google Scholar] [CrossRef]
  36. Kleinewietfeld, M.; Manzel, A.; Titze, J.; Kvakan, H.; Yosef, N.; Linker, R.A.; Muller, D.N.; Hafler, D.A. Sodium chloride drives autoimmune disease by the induction of pathogenic Th17 cells. Nature 2013, 496, 518–522. [Google Scholar] [CrossRef]
  37. Qin, L.; Yao, Z.; Chang, Q.; Zhao, Y.; Liu, N.; Zhu, X.; Liu, Q.; Wang, L.; Yang, A.; Gao, C.; et al. Swimming attenuates inflammation, oxidative stress, and apoptosis in a rat model of dextran sulfate sodium-induced chronic colitis. Oncotarget 2017, 8, 7391–7404. [Google Scholar] [CrossRef] [Green Version]
  38. Jeong, J.K.; Chang, H.K.; Park, K.Y. Doenjang prepared with mixed starter cultures attenuates azoxymethane and dextran sulfate sodium-induced colitis-associated colon carcinogenesis in mice. J. Carcinog. 2014, 13, 9. [Google Scholar]
  39. Morimoto, M.; Watanabe, T.; Yamori, M.; Takebe, M.; Wakatsuki, Y. Isoflavones regulate innate immunity and inhibit experimental colitis. J. Gastroenterol. Hepatol. 2009, 24, 1123–1129. [Google Scholar] [CrossRef]
  40. Hamalainen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E. Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediat. Inflamm. 2007, 2007, 45673. [Google Scholar]
  41. Atreya, I.; Atreya, R.; Neurath, M.F. NF-kappaB in inflammatory bowel disease. J. Intern. Med. 2008, 263, 591–596. [Google Scholar] [CrossRef] [PubMed]
  42. Giridharan, S.; Srinivasan, M. Mechanisms of NF-κB p65 and strategies for therapeutic manipulation. J. Inflamm. Res. 2018, 11, 407–419. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Seibel, J.; Molzberger, A.F.; Hertrampf, T.; Leschowski, U.L.; Diel, P. Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur. J. Nutr. 2009, 48, 213–220. [Google Scholar] [CrossRef] [PubMed]
  44. Wu, G.D.; Bushmanc, F.D.; Lewis, J.D. Diet, the human gut microbiota, and IBD. Anaerobe 2013, 24, 117–120. [Google Scholar] [CrossRef]
  45. Vemuri, R.C.; Gundamaraju, R.; Shinde, T.; Eri, R. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: Antibiotics, probiotics or faecal microbiota transplantation? Benef. Microbes 2017, 8, 179–192. [Google Scholar] [CrossRef]
  46. Rhee, K.J.; Wu, S.; Wu, X.; Huso, D.L.; Karim, B.; Franco, A.A.; Rabizadeh, S.; Golub, J.E.; Mathews, L.E.; Shin, J.; et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect. Immun. 2009, 77, 1708–1718. [Google Scholar] [CrossRef] [Green Version]
  47. Lucke, K.; Miehlke, S.; Jacobs, E.; Schuppler, M. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J. Med. Microbiol. 2006, 55, 617–624. [Google Scholar] [CrossRef]
  48. Balish, E.; Warner, T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 2002, 160, 2253–2257. [Google Scholar] [CrossRef] [Green Version]
  49. Zhou, Y.; Chen, H.; He, H.; Du, Y.; Hu, J.; Li, Y.; Li, Y.; Zhou, Y.; Wang, H.; Chen, Y.; et al. Increased Enterococcus faecalis infection is associated with clinically active Crohn disease. Medicine 2016, 95, e5019. [Google Scholar] [CrossRef]
  50. Dinakaran, V.; Mandape, S.N.; Shuba, K.; Pratap, S.; Sakhare, S.S.; Tabatabai, M.A.; Smoot, D.T.; Farmer-Dixon, C.M.; Kesavalu, L.N.; Adunyah, S.E.; et al. Identification of specific oral and gut pathogens in full thickness colon of colitis patients: Implications for colon motility. Front. Microbiol. 2018, 9, 3220. [Google Scholar] [CrossRef]
  51. Wu, H.; Rao, Q.; Ma, G.C.; Yu, X.H.; Zhang, C.E.; Ma, Z.J. Effect of triptolide on dextran sodium sulfate-induced ulcerative colitis and gut microbiota in mice. Front. Pharmacol. 2019, 10, 1652. [Google Scholar] [CrossRef]
  52. Sun, M.C.; Zhang, F.C.; Yin, X.; Cheng, B.J.; Zhao, C.H.; Wang, Y.L.; Zhang, Z.Z.; Hao, H.W.; Zhang, T.H.; Ye, H.Q. Lactobacillus reuteri F-9-35 prevents DSS-induced colitis by inhibiting proinflammatory gene expression and restoring the gut microbiota in mice. J. Food Sci. 2018, 83, 2645–2652. [Google Scholar] [CrossRef]
  53. Paul, B.; Royston, K.J.; Li, Y.; Stoll, M.L.; Skibola, C.F.; Wilson, L.S.; Barnes, S.; Morrow, C.D.; Tollefsbol, T.O. Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition. PLoS ONE 2017, 12, e0189756. [Google Scholar] [CrossRef] [Green Version]
  54. Ou, W.; Hu, H.; Yang, P.; Dai, J.; Ai, Q.; Zhang, W.; Zhang, Y.; Mai, K. Dietary daidzein improved intestinal health of juvenile turbot in terms of intestinal mucosal barrier function and intestinal microbiota. Fish Shellfish Immunol. 2019, 94, 132–141. [Google Scholar] [CrossRef]
Foods 10 01072 g001 550
Figure 1. Effects of Gochujang on colitis symptoms in DSS-treated rats. (A) Final body weight; (B) weight gain; (C) DAI scores calculated with time (* p < 0.05 vs. DSS group); (D) DAI scores among the groups at day 14. Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b, c) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05. NOR—normal group; DSS—DSS group; SAL—SALT group; MES—mesalamine; GCJ—Gochujang.
Figure 1. Effects of Gochujang on colitis symptoms in DSS-treated rats. (A) Final body weight; (B) weight gain; (C) DAI scores calculated with time (* p < 0.05 vs. DSS group); (D) DAI scores among the groups at day 14. Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b, c) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05. NOR—normal group; DSS—DSS group; SAL—SALT group; MES—mesalamine; GCJ—Gochujang.
Foods 10 01072 g001
Foods 10 01072 g002 550
Figure 2. Effects of Gochujang on colon tissue damage in DSS-treated rats. (A) colon length; (B) colon weight/ length ratio; (C) H&E staining of the colon tissues (black arrow—inflammatory cell infiltration; red arrow—epithelial erosion; black arrowhead—crypt loss). Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05.
Figure 2. Effects of Gochujang on colon tissue damage in DSS-treated rats. (A) colon length; (B) colon weight/ length ratio; (C) H&E staining of the colon tissues (black arrow—inflammatory cell infiltration; red arrow—epithelial erosion; black arrowhead—crypt loss). Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05.
Foods 10 01072 g002
Foods 10 01072 g003 550
Figure 3. Effects of Gochujang on immune response in colon tissue of DSS-treated rats. (A–C) mRNA expression of colonic pro-inflammatory cytokines (TNF-a, IL-6, and IL-1β); (D) expression of inflammatory proteins. Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b, c, d) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05.
Figure 3. Effects of Gochujang on immune response in colon tissue of DSS-treated rats. (A–C) mRNA expression of colonic pro-inflammatory cytokines (TNF-a, IL-6, and IL-1β); (D) expression of inflammatory proteins. Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b, c, d) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05.
Foods 10 01072 g003
Foods 10 01072 g004 550
Figure 4. Effects of Gochujang on relative abundances of gut microbiota in DSS-treated rats at (A) phylum level and (B) order level (n = 7 per group).
Figure 4. Effects of Gochujang on relative abundances of gut microbiota in DSS-treated rats at (A) phylum level and (B) order level (n = 7 per group).
Foods 10 01072 g004
Table
Table 1. Primers used in this study.
Table 1. Primers used in this study.
Gene NamePrimersSequence 5′ to 3′
β-actinForwardCCCGCGAGTACAACCTTCT
ReverseCGTCATCCATGGCGAACT
TNF-α 1ForwardCCCTGGTACTAACTCCCAGAAA
ReverseTGTATGAGAGGGACGGAACC
IL-1βForwardCACCTCTCAAGCAGAGCACAG
ReverseGGGTTCCATGGTGAAGTCAAC
IL-6ForwardTCCTACCCCAACTTCCAATGCTC
ReverseTTGGATGGTCTTGGTCCTTAGCC
1 TNF-α, tumor necrosis factor-alpha; IL-1β, interleukin-1 beta; IL-6, interleukin-6.
Table
Table 2. Effects of Gochujang on serum levels of inflammatory cytokines in DSS-treated rats.
Table 2. Effects of Gochujang on serum levels of inflammatory cytokines in DSS-treated rats.
TNF-α (pg/mL)IL-6 (pg/mL)IL-1β (pg/mL)
NOR49.97 ± 0.21 a238.52 ± 3.42 c43.76 ± 1.02 b
DSS50.47 ± 0.22 a251.52 ± 1.83 a55.66 ± 9.76 a
SAL50.42 ± 0.24 a251.69 ± 1.56 a55.93 ± 11.68 a
MES47.12 ± 1.93 b248.87 ± 1.14 b45.63 ± 1.16 b
GCJ49.89 ± 0.11 a247.73 ± 1.39 b44.81 ± 1.62 b
Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b, c) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05. NOR, normal group; DSS, DSS group; SAL, SALT group; MES, Mesalamine; GCJ, Gochujang.
Table
Table 3. Effects of Gochujang on diversity indexes of the gut microbiota in DSS-treated rats.
Table 3. Effects of Gochujang on diversity indexes of the gut microbiota in DSS-treated rats.
OTUACECHAOSHANNONSIMPSONPhylogenetic Diversity
NOR292.14 ± 30.93 a316.85 ± 32.55 a303.01 ± 31.73 a2.06 ± 0.16 bc0.22 ± 0.04 ab285.29 ± 20.97 a
DSS304.57 ± 41.04 a321.36 ± 42.78 a310.80 ± 41.59 a2.35 ± 0.26 a0.18 ± 0.06 b254.57 ± 41.56 ab
SAL200.00 ± 85.24 b225.02 ± 80.78 b209.94 ± 83.12 b1.91 ± 0.15 c0.26 ± 0.04 a222.43 ± 69.05 b
MES268.29 ± 46.13 a290.75 ± 42.59 a277.57 ± 43.95 a2.01 ± 0.18 c0.27 ± 0.07 a282.43 ± 18.88 a
GCJ313.57 ± 53.54 a334.62 ± 53.11 a321.00 ± 52.90 a2.24 ± 0.19 ab0.20 ± 0.06 b284.86 ± 42.51 a
Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b, c) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05.
Table
Table 4. Effects of Gochujang on relative abundances of gut microbiota at species level in DSS-treated rats.
Table 4. Effects of Gochujang on relative abundances of gut microbiota at species level in DSS-treated rats.
SpeciesComposition (%)
NORDSSSALMESGCJ
Enterococcus faecalis1.57 ± 0.53 bc8.37 ± 5.91 a4.79 ± 2.31 b2.66 ± 2.13 bc1.15 ± 0.59 c
Staphylococcus sciuri group1.61 ± 1.38 b15.34 ± 11.69 a5.69 ± 4.25 b0.82 ± 0.80 b3.02 ± 3.03 b
Akkermansia muciniphila0.04 ± 0.04 b0.04 ± 0.04 b0.08 ± 0.08 b0.17 ± 0.10 ab0.25 ± 0.26 a
Enterococcus faecium group25.75 ± 6.88 bc21.51 ± 6.88 c42.59 ± 9.36 a38.30 ± 19.89 ab32.61 ± 13.56 abc
Escherichia coli group26.58 ± 11.9418.54 ± 12.1617.61 ± 12.6622.65 ± 15.4615.16 ± 7.62
Lactobacillus reuteri group0.06 ± 0.060.01 ± 0.010.00 ± 0.000.01 ± 0.010.14 ± 0.28
Data are expressed as the mean ± SD (n = 7 per group). Values with different superscripts (a, b, c) are significantly different among groups according to ANOVA with Duncan’s multiple range test at p < 0.05.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mahoro, P.; Moon, H.-J.; Yang, H.-J.; Kim, K.-A.; Cha, Y.-S. Protective Effect of Gochujang on Inflammation in a DSS-Induced Colitis Rat Model. Foods 2021, 10, 1072. https://doi.org/10.3390/foods10051072

AMA Style

Mahoro P, Moon H-J, Yang H-J, Kim K-A, Cha Y-S. Protective Effect of Gochujang on Inflammation in a DSS-Induced Colitis Rat Model. Foods. 2021; 10(5):1072. https://doi.org/10.3390/foods10051072

Chicago/Turabian Style

Mahoro, Patience, Hye-Jung Moon, Hee-Jong Yang, Kyung-Ah Kim, and Youn-Soo Cha. 2021. "Protective Effect of Gochujang on Inflammation in a DSS-Induced Colitis Rat Model" Foods 10, no. 5: 1072. https://doi.org/10.3390/foods10051072

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop